Health Policy for Prostate Cancer Early Detection in the
European Union and the Impact of Opportunistic Screening:
PRAISE-U Consortium

J 2024

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

BEYER, Katharina; Renee LEENEN; Lionne D F VENDERBOS; Jozien HELLEMAN; Frederique DENIJS et. al.

Základní údaje

Originální název

Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

Autoři

BEYER, Katharina; Renee LEENEN; Lionne D F VENDERBOS; Jozien HELLEMAN; Frederique DENIJS; Wichor BRAMER; Vera VASILYEVA; Erik BRIERS; Juan Gomez RIVAS; Renata CHLOUPKOVÁ (203 Česká republika, domácí); Ondřej MÁJEK (203 Česká republika, domácí); Lieven ANNEMANS; Pieter VYNCKIER; Partha BASU; Arunah CHANDRAN; van den Bergh RODERICK; Sarah COLLEN; van Poppel HENDRIK a Monique J ROOBOL

Vydání

Journal of Personalized Medicine, Basel, MDPI, 2024, 2075-4426

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.000 v roce 2023

Kód RIV

RIV/00216224:14110/24:00136126

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.3390/jpm14010084

UT WoS

001151281700001

EID Scopus

2-s2.0-85183183984

Klíčová slova anglicky

prostate cancer; screening; early detection; policy; health policy

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 5. 6. 2024 09:58, Mgr. Tereza Miškechová

Anotace

V originále

With the new policy recommendation in 2022 to explore the possibilities of screening for prostate cancer by the European Commission, the landscape for prostate cancer early detection is evolving. In line with this recommendation, the PRAISE-U project aims to evaluate the early detection and diagnosis of prostate cancer through customised and risk-based screening programmes, with the goal to align protocols across European Union member states. This systematic review is part of the PRAISE-U project, with the goal to review the policy, medical guideline recommendations, and the current level of opportunistic screening presented in the scientific literature on prostate cancer early detection from 2016 to 2023 in European Union member states. An extensive literature search was performed on 1 June 2023 in a large number of databases, including Embase.com, Medline (Ovid), Web of Science Core Collection, Google Scholar, and Policy Commons. We identified 318 articles (qualitative, quantitative, and reviews), of which 41 were included in the full-text screening. Seventeen articles were ultimately identified as eligible for inclusion. The included articles revealed significant variations towards PSA-based early detection policies for prostate cancer in nine European countries. Despite official recommendations, opportunistic screening was prevalent across all nine countries regardless of recommendations for or against PSA-based early detection. This systematic review suggests that the current early detection policies are not fit for purpose. High levels of opportunistic screening and overdiagnosis persist, prompting policy recommendations for standardised guidelines, informed decision making, and increased awareness to improve efficiency and effectiveness in early detection.

Citovat

BEYER, Katharina; Renee LEENEN; Lionne D F VENDERBOS; Jozien HELLEMAN; Frederique DENIJS; Wichor BRAMER; Vera VASILYEVA; Erik BRIERS; Juan Gomez RIVAS; Renata CHLOUPKOVÁ; Ondřej MÁJEK; Lieven ANNEMANS; Pieter VYNCKIER; Partha BASU; Arunah CHANDRAN; van den Bergh RODERICK; Sarah COLLEN; van Poppel HENDRIK a Monique J ROOBOL. Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium. Journal of Personalized Medicine. Basel: MDPI, 2024, roč. 14, č. 1, s. 1-12. ISSN 2075-4426. Dostupné z: https://doi.org/10.3390/jpm14010084.

@article{2407840,
   author = {Beyer, Katharina and Leenen, Renee and Venderbos, Lionne D F and Helleman, Jozien and Denijs, Frederique and Bramer, Wichor and Vasilyeva, Vera and Briers, Erik and Rivas, Juan Gomez and Chloupková, Renata and Májek, Ondřej and Annemans, Lieven and Vynckier, Pieter and Basu, Partha and Chandran, Arunah and Roderick, van den Bergh and Collen, Sarah and Hendrik, van Poppel and Roobol, Monique J},
   article_location = {Basel},
   article_number = {1},
   doi = {https://doi.org/10.3390/jpm14010084},
   keywords = {prostate cancer; screening; early detection; policy; health policy},
   language = {eng},
   issn = {2075-4426},
   journal = {Journal of Personalized Medicine},
   title = {Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium},
   url = {https://www.mdpi.com/2075-4426/14/1/84},
   volume = {14},
   year = {2024}
}

TY  - JOUR
ID  - 2407840
AU  - Beyer, Katharina - Leenen, Renee - Venderbos, Lionne D F - Helleman, Jozien - Denijs, Frederique - Bramer, Wichor - Vasilyeva, Vera - Briers, Erik - Rivas, Juan Gomez - Chloupková, Renata - Májek, Ondřej - Annemans, Lieven - Vynckier, Pieter - Basu, Partha - Chandran, Arunah - Roderick, van den Bergh - Collen, Sarah - Hendrik, van Poppel - Roobol, Monique J
PY  - 2024
TI  - Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium
JF  - Journal of Personalized Medicine
VL  - 14
IS  - 1
SP  - 1-12
EP  - 1-12
PB  - MDPI
SN  - 20754426
KW  - prostate cancer
KW  - screening
KW  - early detection
KW  - policy
KW  - health policy
UR  - https://www.mdpi.com/2075-4426/14/1/84
N2  - With the new policy recommendation in 2022 to explore the possibilities of screening for prostate cancer by the European Commission, the landscape for prostate cancer early detection is evolving. In line with this recommendation, the PRAISE-U project aims to evaluate the early detection and diagnosis of prostate cancer through customised and risk-based screening programmes, with the goal to align protocols across European Union member states. This systematic review is part of the PRAISE-U project, with the goal to review the policy, medical guideline recommendations, and the current level of opportunistic screening presented in the scientific literature on prostate cancer early detection from 2016 to 2023 in European Union member states. An extensive literature search was performed on 1 June 2023 in a large number of databases, including Embase.com, Medline (Ovid), Web of Science Core Collection, Google Scholar, and Policy Commons. We identified 318 articles (qualitative, quantitative, and reviews), of which 41 were included in the full-text screening. Seventeen articles were ultimately identified as eligible for inclusion. The included articles revealed significant variations towards PSA-based early detection policies for prostate cancer in nine European countries. Despite official recommendations, opportunistic screening was prevalent across all nine countries regardless of recommendations for or against PSA-based early detection. This systematic review suggests that the current early detection policies are not fit for purpose. High levels of opportunistic screening and overdiagnosis persist, prompting policy recommendations for standardised guidelines, informed decision making, and increased awareness to improve efficiency and effectiveness in early detection.
ER  -

BEYER, Katharina; Renee LEENEN; Lionne D F VENDERBOS; Jozien HELLEMAN; Frederique DENIJS; Wichor BRAMER; Vera VASILYEVA; Erik BRIERS; Juan Gomez RIVAS; Renata CHLOUPKOVÁ; Ondřej MÁJEK; Lieven ANNEMANS; Pieter VYNCKIER; Partha BASU; Arunah CHANDRAN; van den Bergh RODERICK; Sarah COLLEN; van Poppel HENDRIK a Monique J ROOBOL. Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium. \textit{Journal of Personalized Medicine}. Basel: MDPI, 2024, roč.~14, č.~1, s.~1-12. ISSN~2075-4426. Dostupné z: https://doi.org/10.3390/jpm14010084.

Přehled o publikaci